Supplemental Experimental Procedures

In Vitro Transcriptions
Typically, 100ng of DNA template was used in the in vitro transcription assays. Affinity-purified TFIID was purified as described (Jacq et al., 1994; Lewis et al., 2000) . Reconstituted in vitro transcription assays contained rTFIIA (1.8 pmol), rTFIIB (2.8 pmol), rTFIIE (0.16 pmol), rTFIIF (1.24 pmol) (Maldonado et al., 1996a) . TFIIH is a partially purified phenyl-Superose fraction (0.375 µg) (Maldonado et al., 1996a) . RNA polymerase II was purified to homogeneity as described (0.8 pmol) (Maldonado et al., 1996a) . TFIID concentrations used in the in vitro transcriptions were determined empirically by titration and correspond to saturating amounts of each. Flag-Sp1 (2.8 pmol) was purified from baculovirus infected Sf9 cells using M2 resin (Sigma) affinity chromatography. rCK2β was purified by standard native purification protocols (Qiagen). Recombinant CK2 was purchased from NEB or Upstate. rPC4 was purified as described (Ge et al., 1996) . CK2 peptide (NEB) or FLAG peptide (Sigma) were titrated into HeLa nuclear extracts at the following final concentrations: 48µM, 240µM, and 480µM. rCK2 (NEB) optimal concentrations were 500U per reaction (500ng).
Template Construction
DPE and mDPE templates are based on Sp1/βInr templates (Lewis and Orkin, 1995) . Positions -5 to +9 are the β-globin initiator region and +10 to +40 are from the human IRF-1 promoter (Burke and Kadonaga, 1997; Sims et al., 1993) . Note that the spacing between the DPE and the +1 start site is conserved between the human IRF-1 promoter and the DPE template construct. These were synthesized as a contiguous sequence, assembled as a double-stranded oligomer, and inserted into the SmaI site of pSp1 (Smale and Baltimore, 1989) .
Chromatin Immunoprecipitation
Briefly, HeLa cells were treated or untreated with IFNγ (Sigma I3265) (Sims et al., 1993) for 3 hours and crosslinked with 1% formaldehyde. After cell lysis, cells were sonicated and diluted to an absorbance of A 260 units/ml. The diluted lysate was pre-cleared for 1 hour and incubated with antibody overnight. The immuno-complexes were precipitated with protein-G beads, washed extensively, and eluted. The eluted fractions were incubated with 1M NaCl for 4 hours at 65 o C, followed by an 1 hour incubation with proteinase K. The samples were purified by a phenol:cholorform extraction and ethanol precipitation. Varying amounts of samples were PCR amplified using 35-40 cycles. The primers used for PCR were as follows: (IRF-1 5'-promoter: AATCCCGCTAAGTGTTTGGATTGCTCGG); (IRF-1 3'-promoter: AGT GGA AGA GGG AAG AAG GCA GAG GTT); (IRF-1 5'-coding: AAG GCC AAC TTT CGC TGT GCC ATG AA); (IRF-1 3'-coding: AGC ATC TCG GCT GGA CTT CGA CTT TCTT). TAF7-5':TAT TGC GCC TGC GCT AGC TGGG, TAF7-3':AGC CGA GCG TCT CCT TGT CGT TTC CTT AAT, Cyclin D1-5': TTC TCT GCC GGG CTT TGA TCT TTG CT, Cyclin D1-3': TCG GCT CTC GCT TCT GCT GCC.
The antibodies used for immunoprecipitation were anti-acetyl histone H3 (Upstate #06-599), anti-histone H3-K4 tri-methyl (Sarma et al., 2004) , anti-histone H3-K9 tri-methyl (Sarma et al., 2004) , anti-PC4 (Cho et al., 1998 ), anti-MED10 (Akoulitchev et al., 2000 , anti-MED23/Sur2 (Boyer et al., 1999) , anti-Rbp4 (FC78391), anti-TBP (1C2) (Lescure et al., 1994) , anti-TFIIF/RAP74 (7B3/E10) (Cho et al., 1998) , anti-TFIIH/ERCC3 (8B6) (LeRoy et al., 1998), anti-CTD (Maldonado et al., 1996b) , anti-CK2α (Santa Cruz #sc-12738), anti-CK2β (BD Biosciences #610443).
DSA Purification
DSA was purified by passing 18g (2L) nuclear extract over a P11 resin (Whatman) and step eluting with 0.3M, 0.5M, and 1M KCl in BC buffer (20mM Tris pH7.9, 20% glycerol, 0.5mM DTT, 0.4mM EDTA). The 1M fraction was passed over a DE52 resin (Whatman). The DE52 flow-through was passed through heparin-agarose (Sigma). DSA was eluted with BC400, dialyzed to BC100, and passed through a HPLC monoS column (Amersham). The column was developed with a BC100-BC1000 KCl gradient. The fractions were dialyzed against BC100 and assayed in the purified in vitro transcription system on DPE promoter templates. MonoS fractions were pooled and concentrated using a Centricon filter and applied to a Superose 6 column (Amersham) and developed in BC500. The relevant 2MDa and 100kDa fractions were dialyzed into BC100 and applied to monoQ columns, which were developed with BC100-1000 KCl gradients. In each step of the purification, aliquots of the fractions were dialyzed into BC100 before assaying transcriptionally.
Mass Spectroscopy
CK2 was isolated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis after staining with colloidal Coomassie Blue (Invitrogen) and then subjected to reduction, carboxyamidomethylation, and digestion with trypsin. Peptides were analyzed by microcapillary reversed-phase high-pressure liquid chromatography nanoelectrospray tandem mass spectrometry on a Finnigan LCQ DECA XP Plus quadrupole ion trap mass spectrometer (Thermo Electron). A normalized collision energy of 30% and with an isolation width of 2.5 Da was used, with recurring ions dynamically excluded. Preliminary mapping of peptide sequences was accomplished with the SEQUEST algorithm, followed by manual validation.
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